The $ 3.2 billion deal announced by the Biden administration comes as federal scientists consider how to update vaccines to better protect Americans against the rapidly evolving virus.
Federal officials said the purchase agreement includes the option to purchase a total of 300 million installments, including a mix of installments for both adults and children.
The first shots will be taken in early autumn, pending the decision of the Food and Drug Administration to approve new versions of the shots.
A decision by the FDA is expected in the days following Tuesday’s meeting, at which external advisers recommended modifying the vaccines to better target the micron variant.
Current vaccines maintain strong protection against hospitalization and death, but their ability to prevent infection was significantly reduced when omicron appeared.
It is unknown at this time what he will do after leaving the post. But once the FDA decides to change the prescription, Pfizer and rival Moderna will have to seek approval for properly updated doses, time for health authorities to come up with a downside strategy.
Wednesday’s announcement came as Congress remained at a dead end in funding the Biden administration’s billions in funding to purchase additional vaccines, trials and drugs to fight the pandemic.
Lawmakers in Parliament and the Senate have been at loggerheads for weeks over how to resolve the stalemate. Funding for Pfizer’s latest purchase comes from reallocated money from previous COVID-19 relief packages, officials said.
Copyright © 2022 by the Associated Press. All rights reserved.
U.S. health officials agreed to purchase 105 million COVID vaccine doses for fall campaign Source link U.S. health officials agreed to purchase 105 million COVID vaccine doses for fall campaign